Tris Pharma
Heidi Bobb is a Senior Specialty CNS Healthcare Sales Professional at Tris Pharma, where experience includes significant contributions to sales growth of key products for pediatric and psychiatry physicians since May 2019. Previously, Bobb held roles at Touchpoint Solutions-TRIS Pharma and Publicis Touchpoint Solutions-Pfizer, focusing on specialty pharmaceutical sales and product launches, including the introduction of QuilliChewER. Earlier roles at Quintiles involved various responsibilities, including pharmaceutical sales and district training, with a demonstrated ability to drive sales for numerous therapeutic products across multiple specialties, including internal medicine and primary care. Heidi Bobb holds a Bachelor of Fine Arts in Communications/Fine Art from Southern Illinois University, Carbondale.
This person is not in any offices
Tris Pharma
1 followers
Tris Pharma, Inc. is one of the top five privately-owned specialty pharmaceutical companies in the U.S. with a focus on the development of pharmaceutical science and technology-based products. Specifically, we are engaged in research, development, manufacturing, and commercialization of both branded products and specialty generic products. We have more than a dozen solid and liquid products in the U.S. market based on our numerous NDAs and ANDAs and a rich and growing portfolio of more than 30 U.S. granted patents. Our commercialization success is driven by internal resources for our pediatric products and by licensing of our non-pediatric products to other companies.